| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SKILLZ INC | 1 | Q4 2020 | 73.8% |
| INTELLIA THERAPEUTICS INC | 1 | Q4 2020 | 13.9% |
| SURFACE ONCOLOGY INC | 1 | Q4 2020 | 4.3% |
| SPERO THERAPEUTICS INC | 1 | Q4 2020 | 4.2% |
| COGENT BIOSCIENCES INC | 1 | Q4 2020 | 1.6% |
| SNAP INC | 1 | Q4 2020 | 1.2% |
| SYNLOGIC INC | 1 | Q4 2020 | 0.9% |
| 0 | 1 | Q4 2020 | 0.0% |
View Atlas Venture Associates XI, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-02-28 |
| 4 | 2024-02-23 |
| 4 | 2024-02-20 |
| 4 | 2024-02-09 |
| 4 | 2024-01-16 |
| 3 | 2023-11-07 |
| 4 | 2022-12-14 |
| 4 | 2022-09-19 |
| 3 | 2022-09-14 |
| 4 | 2022-06-22 |
View Atlas Venture Associates XI, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.